Malattia di Devic (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Malattia di Devic" in Italian language version.

refsWebsite

Global rank Italian rank

8doi.org

2^nd place

7^th place

8nih.gov

4^th place

9^th place

4oadoi.org

799^th place

22^nd place

2ama-assn.org

3,257^th place

5,565^th place

1archive.org

6^th place

8^th place

1jem.org

low place

1mayoclinic.org

1,610^th place

3,832^nd place

ama-assn.org

archneur.ama-assn.org

Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA, Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression, in Arch. Neurol., vol. 63, n. 7, 2006, pp. 964–8, DOI:10.1001/archneur.63.7.964, PMID 16831965.
Weinstock-Guttman B, Ramanathan M, Lincoff N, et al., Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease), in Arch. Neurol., vol. 63, n. 7, 2006, pp. 957–63, DOI:10.1001/archneur.63.7.957, PMID 16831964.

archive.org

Lucchinetti CF, Mandler RN, McGavern D, et al., A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica, in Brain, vol. 125, Pt 7, 2002, pp. 1450–61, DOI:10.1093/brain/awf151, PMID 12076996.

doi.org

dx.doi.org

Lucchinetti CF, Mandler RN, McGavern D, et al., A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica, in Brain, vol. 125, Pt 7, 2002, pp. 1450–61, DOI:10.1093/brain/awf151, PMID 12076996.
Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA, Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression, in Arch. Neurol., vol. 63, n. 7, 2006, pp. 964–8, DOI:10.1001/archneur.63.7.964, PMID 16831965.
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR, IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel, in J. Exp. Med., vol. 202, n. 4, 2005, pp. 473–7, DOI:10.1084/jem.20050304, PMID 16087714.
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG, Revised diagnostic criteria for neuromyelitis optica, in Neurology, vol. 66, n. 10, 2006, pp. 1485–9, DOI:10.1212/01.wnl.0000216139.44259.74, PMID 16717206.
Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG, Neuromyelitis optica, in Curr. Opin. Neurol., vol. 20, n. 3, 2007, pp. 255–60, DOI:10.1097/WCO.0b013e32814f1c6b, PMID 17495617.
Weinstock-Guttman B, Ramanathan M, Lincoff N, et al., Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease), in Arch. Neurol., vol. 63, n. 7, 2006, pp. 957–63, DOI:10.1001/archneur.63.7.957, PMID 16831964.
Watanabe S, Misu T, Miyazawa I, et al., Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis, in Multiple Sclerosis, vol. 13, 2007, pp. 968, DOI:10.1177/1352458507077189, PMID 17623727.
Gartzen K, Limmroth V, Putzki N, Relapsing neuromyelitis optica responsive to glatiramer acetate treatment, in Eur. J. Neurol., vol. 14, n. 6, 2007, pp. e12–3, DOI:10.1111/j.1468-1331.2007.01807.x, PMID 17539924.

jem.org

Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR, IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel, in J. Exp. Med., vol. 202, n. 4, 2005, pp. 473–7, DOI:10.1084/jem.20050304, PMID 16087714.

mayoclinic.org

Mayo Clinic, Devic's Disease Symptoms, su mayoclinic.org. URL consultato l'11 marzo 2008.

nih.gov

ncbi.nlm.nih.gov

Lucchinetti CF, Mandler RN, McGavern D, et al., A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica, in Brain, vol. 125, Pt 7, 2002, pp. 1450–61, DOI:10.1093/brain/awf151, PMID 12076996.
Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA, Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression, in Arch. Neurol., vol. 63, n. 7, 2006, pp. 964–8, DOI:10.1001/archneur.63.7.964, PMID 16831965.
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR, IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel, in J. Exp. Med., vol. 202, n. 4, 2005, pp. 473–7, DOI:10.1084/jem.20050304, PMID 16087714.
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG, Revised diagnostic criteria for neuromyelitis optica, in Neurology, vol. 66, n. 10, 2006, pp. 1485–9, DOI:10.1212/01.wnl.0000216139.44259.74, PMID 16717206.
Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG, Neuromyelitis optica, in Curr. Opin. Neurol., vol. 20, n. 3, 2007, pp. 255–60, DOI:10.1097/WCO.0b013e32814f1c6b, PMID 17495617.
Weinstock-Guttman B, Ramanathan M, Lincoff N, et al., Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease), in Arch. Neurol., vol. 63, n. 7, 2006, pp. 957–63, DOI:10.1001/archneur.63.7.957, PMID 16831964.
Watanabe S, Misu T, Miyazawa I, et al., Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis, in Multiple Sclerosis, vol. 13, 2007, pp. 968, DOI:10.1177/1352458507077189, PMID 17623727.
Gartzen K, Limmroth V, Putzki N, Relapsing neuromyelitis optica responsive to glatiramer acetate treatment, in Eur. J. Neurol., vol. 14, n. 6, 2007, pp. e12–3, DOI:10.1111/j.1468-1331.2007.01807.x, PMID 17539924.

oadoi.org

Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG, Revised diagnostic criteria for neuromyelitis optica, in Neurology, vol. 66, n. 10, 2006, pp. 1485–9, DOI:10.1212/01.wnl.0000216139.44259.74, PMID 16717206.
Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG, Neuromyelitis optica, in Curr. Opin. Neurol., vol. 20, n. 3, 2007, pp. 255–60, DOI:10.1097/WCO.0b013e32814f1c6b, PMID 17495617.
Watanabe S, Misu T, Miyazawa I, et al., Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis, in Multiple Sclerosis, vol. 13, 2007, pp. 968, DOI:10.1177/1352458507077189, PMID 17623727.
Gartzen K, Limmroth V, Putzki N, Relapsing neuromyelitis optica responsive to glatiramer acetate treatment, in Eur. J. Neurol., vol. 14, n. 6, 2007, pp. e12–3, DOI:10.1111/j.1468-1331.2007.01807.x, PMID 17539924.